Role of Corticosteroids in Septic Shock

Annals of Pharmacotherapy

Volumn 38, Issue 3, 2004, Pages 464-472

  Burry, Lisa D ^a   Wax, Randy S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Adrenal insufficiency; Corticosteroids; Sepsis; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; NORADRENALIN; PREDNISOLONE;

ADRENAL INSUFFICIENCY; ARTICLE; AUTOMATION; CLINICAL TRIAL; COCHRANE LIBRARY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; CRITICAL ILLNESS; DRUG ABSORPTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; EMBASE; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE; INTENSIVE CARE UNIT; LOW DRUG DOSE; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLICATION; REVIEW; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SUPERINFECTION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; SEPSIS; SHOCK, SEPTIC;

EID: 1242316354     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C435     Document Type: Review

References (76)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 1992;101:1644-55.
2. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(suppl 7):S109-16.
3. Hardaway RM. A review of septic shock. Am Surg 2000;66:22-9.
4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
5. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
6. Natanson C, Hofmann WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanism of pathogenesis. Ann Intern Med 1994;120:771-83.
7. Matthay M. A severe sepsis-a new treatment with both anticoagulant and anti-inflammatory properties. N Engl J Med 2001;344:759-62.
8. Bernard GR, Vincent J-L, Laterre P-F, LaRosa SP, Dhainaut J-F, Rodriguez AL, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
9. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. The Early Goal-Directed Therapy Collaborative Group. Early goal- directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;10:1644-55.
11. Vincent JL, Moreno R, Willatts S, Demendonca A, Bruining H, Reinhart CK, et al. The SOFA score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707-10.
12. Briegel J. Hydrocortisone and the reduction of vasopressors in septic shock: therapy or only chart cosmetics? Intensive Care Med 2000;26:1723-6.
13. Spijkstra JJ, Girbes ARJ. The continuing story of corticosteroids in the treatment of septic shock. Intensive Care Med 2000;26:496-500.
14. Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001;27:1584-91.
15. Beishuizen A, Vermes I, Haanen C. Endogenous mediators in sepsis and septic shock. Adv Clin Chem 1998;33:55-131.
16. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246-53.
17. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-96.
18. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-34.
19. Pugeat M, Bonneton A, Perrot D. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. Clin Chem 1989;35:1675-9.
20. Schein RMH, Sprung CL, Marcial E, Napolitano L, Chernow B. Plasma cortisol levels in septic shock. Crit Care Med 1990;18:259-63.
21. Annane D, Bellissant E, Bollaert PE. The hypothalamo-pituitary axis in septic shock. Br J Intensive Care 1996;6:260-8.
22. Lamberts SWJ, Bruining HA, De Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997;333:1285-92.
23. Schroeder S, Wichers M, Klingmuller D, Hofer M, Lehmann LE, von Spiegel T, et al. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med 2001;29:310-6.
24. Gaillard RC, Turnhill D, Sappino P, Muller AF. Tumor necrosis factor inhibits response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990;127:101-6.
25. Jaaleta M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotrop induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991;128:688-90.
26. Williams GH, Dluhy RG. Diseases of the adrenal cortex. In: Wilson JD, Braunwald E, Isselbacher RJ, eds. Harrison's principles of internal medicine. 12th ed. New York: McGraw-Hill, 1991:1718.
27. Salern M, Tainsh RE, Brombert J. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg 1994;4:416-25.
28. Streeten DHP. What test for hypothalamic-pituitary adrenocortical insufficiency? Lancet 1999;354:179-80.
29. Jenkins RC, Ross RJM. The endocrinology of the critically ill: current opinion. Curr Opin Endocrinol Diab 1996;3:138-45.
30. Rothwell PM, Lawler PF. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995;23:78-83.
31. Drucker D, Shandling M. Variable adrenocortical function in acute medical illness. Crit Care Med 1985;13:477-9.
32. Jurney TH, Cockrell JL, Lindberg JS, Lamiell JM, Wade CE. Spectrum of serum cortisol response to ACTH in ICU patients: correlation with degree of illness and mortality. Chest 1987;92:292-5.
33. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337:582-3.
34. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;322:1351-62.
35. Span FR, Mermus ARMM, Bartelink AKM. Adrenocortical function. Intensive Care Med 1992;18:93-6.
36. Jarek MJ, Legare EJ, McDermott MT, Merenich JA, Kollef MH. Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 1993;21:543-50.
37. Aygen B, Inan M, Doganay M, Kelestimur F. Adrenal functions in patients with sepsis. Exp Clin Endocrinol Diab 1997;105:182-6.
38. Annane D, Sebille V, Tgroche G, Raphael J-C, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
39. Van De Berghe G, De Zegher F, Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-34.
40. Sibbald WJ, Sjort A, Cohen MP, Wilson FT. Variation in adrenocortical responsiveness during severe bacterial infections. Ann Surg 1977;186:29-33.
41. Finlay WEI, McKeel JL. Serum cortisol levels in severely stressed patients. Lancet 1982;1:1414-45.
42. McKee JL, Finlay WE. Cortisol replacement in severely stressed patients. Lancet 1983;1:484.
43. Bouachour G, Tirot P, Gouello JP, Mathieu E, Vincent JF, Alquier P. Adrenal cortical function during septic shock. Intensive Care Med 1995;21:57-62.
44. Voerman HJ, Strack van Scheindel RJM, Groeneveld ABJ, de Boer H, Nauta JP, Thijs LG. Pulsatile hormone secretion during severe sepsis: accuracy of different blood sampling regimens. Metabolism 1992;82:934-40.
45. Bouachour G, Roy PM, Guiraud MP. The repetitive short corticotropin stimulation test in patients with septic shock. Ann Intern Med 1995;123:962-3.
46. Moran A, Chapman MJ, O'Fathartaigh MS, Peisach AR, Pannall PR, Leppard P. Hypocortisolaemia and adrenocortical responsiveness and onset of septic shock. Intensive Care Med 1994;20:489-95.
47. Dicksterin G, Shechner C, Nicholson W, Rosner I, Shen-orr Z, Adawi F, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991;72:773-8.
48. Nye E, Grice J, Hockings GI, Strakosch CR, Crosbie G, Walters M, et al. Comparison of ACTH stimulation tests and insulin hypoglycemia in normal humans: low-dose, standard high dose, and 8-hour ACTH infusion tests. J Clin Endocrinol Metab 1999;84:3648-55.
49. Darmon P, Dadoun F, Frachebois C, Velut J-G, Dutour A, Oliver C, et al. On the meaning of low-dose ACTH tests to assess functionality of the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 1999;140:51-5.
50. Yamashita S, Drynan J, Guest C, Silverberg J. Comparison of low-dose 1 μg with conventional dose cosyntropin 250 pg for adrenal insufficiency testing in critical illness (abstract). Crit Care Med 2001;29(suppl): A164.
51. Richards ML, Caplan RH, Wickus GG, Lambert PJ, Kisken WA. The rapid low-dose cosyntropin test in the immediate postoperative period: results in elderly subjects after major abdominal surgery. Surgery 1999;125:431-40.
52. Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test, the conventional dose short synacthen test, and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999;84:838-43.
53. Marik PE, Kiminyo K, Zaloga GP. Adrenal insufficiency in critically ill HIV infected patients. Crit Care Med 2002;30:1267-73.
54. Ligtenberg JJM, Girbes ARJ, Beentjes JAM, Tulleken JE, van der Werf TS, Zijlstra JG. Hormones in the critically ill patient: to intervene or not to intervene? Intensive Care Med 2001;27:1567-77.
55. Collins S, Caron MG, Lefkowita FJ. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Invest 1991;88:385-9.
56. Saito T, Takanashi M, Gallagher E. Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 1995;21:204-10.
57. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Resp Crit Care Med 1995;152:838-60.
58. Walker BR, Williams BC. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci 1992;82:597-605.
59. Sjolin J. High-dose corticosteroid therapy in human septic shock: has the jury reached a correct verdict? Circ Shock 1991;35:139-51.
60. De Bel EE. Reduced nitric oxide production after corticosteroid administration in severe sepsis. In: Rousos C, ed. 8th European Congress of Intensive Care Medicine, II. 1995. Free papers, 17.
61. Finkel MS, Oddis CV, Jacob TD. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
62. Silverman HJ, Penaranda R, Orens JB. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993;21:31-9.
63. Breslow MJ, Ligier B. Hyperadrenergic states. Crit Care Med 1991;19:1566-79.
64. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-50.
65. Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC, et al. Impaired pressor sensitivity to norepinephrine in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998;46:591-9.
66. Bellissant E, Annane D. Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 2000;68:293-303.
67. Annane D. Corticosteroids for septic shock. Crit Care Med 2001;29(7 suppl):S117-20.
68. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticosteroid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659-65.
69. Bone RC, Fisher C Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
70. Lefering R, Neugebauer EAM. Steroids controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
71. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis. Crit Care Med 1995;23:1430-9.
72. Chawla K, Kupfer Y, Tessler S. Hydrocortisone reverses refractory septic shock (abstract). Crit Care Med 1999;27:A33.
73. Keh D, Weber-Carstens S, Bohnke T, Schulz C, Pettersson M, Ahlers O, et al. Effects of stress-dose hydrocortisone therapy in septic shock (part I): influence on hemodynamic stability and plasma nitrite/nitrate levels. Preliminary results of a double blind, randomized, placebo-controlled cross-over study (abstract). Crit Care 1999;3:51.
74. Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur F, Tutus A. Physiological-dose of steroid therapy in sepsis. Crit Care 2002;6:251-8.
75. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-32.
76. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.